Antimicrobial peptides based on tripeptide repeats
View Patent ↗The invention described herein relates to compositions of novel antimicrobial peptides that comprise hydrophobic and cationic residues, based on monomeric tri-peptide units. The peptides of the present invention exhibit high antibacterial activity and low hemolytic activity. The invention further provides compositions comprising these antimicrobial peptides and methods of use thereof for killing, reducing the growth of, or preventing the growth of microorganisms. The invention also provides antimicrobial substrates, medical devices, protective garments and barrier materials comprising the peptides of the present invention.
1. An antimicrobial oligopeptide comprising monomeric tri-peptide units according to:
(XZX) n; Formula (IV):
wherein:
X is a hydrophobic amino acid independently selected from the group consisting of Leu and Ala, with the proviso that only one Ala residue is permitted per monomeric tri-peptide unit;
Z is a cationic amino acid independently selected from the group consisting of Lys, Orn, and Dab; and
n=5 to 100
and wherein the antimicrobial oligopeptide exhbits antimicrobial activity and low hemolytic activity.
2. An antimicrobial oligopeptide of claim 1 , wherein Z is Lys.
3. The antimicrobial oligopeptide of claims 1 , wherein n=5 to 50.
4. The antimicrobial oligopeptide of claims 1 , wherein n=5 to 10.
5. The antimicrobial oligopeptide of claims 1 , wherein the antimicrobial peptide further comprises an additional one to three uncharged or cationic amino acids at the N-terminus, C-terminus, or a combination thereof.
6. The antimicrobial oligopeptide of claims 1 , wherein the antimicrobial peptide is modified on the N-terminus with an acetyl group; modified on the C-terminus with an amide; or a combination thereof.
7. The antimicrobial oligopeptide of claim 5 , wherein the antimicrobial peptide is modified on the N-terminus with an acetyl group; modified on the C-terminus with an amide; or a combination thereof.
8. An antimicrobial substrate comprising the antimicrobial oligopeptide of claims 1 bound to or incorporated into a substrate.
9. The substrate of claim 8 selected from the group consisting of (i) polymers selected from the group consisting of latex, polyvinyl chloride, polyimide, polyesters, polyethylene, polypropylene, polyamides, polyacrylates, polyolefins, polysaccharides, polyurethane, polysulfone, polyethersulfone, polycarbonate, fluoropolymers, cellulosics, synthetic rubber, silk, silicone, and mixtures thereof; (ii) functionalized polymers selected from the polymers of (i); (iii) ceramics; (iv) glass; (v) metal, (vi) metal oxides, and (vii) composites comprising at least one of the polymers of (i) and at least one of the group consisting of (iii), (iv), (v) and (vi).
10. The substrate of claim 9 comprising a functionalized polymer.
11. An article comprising the antimicrobial substrate of claim 8 .
12. The article of claim 11 in the form of a film, membrane, laminate, knit fabric, woven fabric, nonwoven fabric, fiber, filament, yarn, pellet, coating, or foam.
13. An article of claim 11 which has been blown, solution cast, laminated, injection molded, extruded, blow molded, thermoformed, knit, woven, or spun.
14. An article of claim 11 selected from the group consisting of a package; a cosmetic; a personal hygiene article; a food containing article; a food processing article; a food delivering article; a cosmetic application; an inhaler; a medical device; a pharmaceutical or diagnostic container or applicator; a food or seed; a baby item; a personal garment; a medical garment; an agricultural item; a household item; and a separation membrane.
15. A process for preparing an antimicrobial substrate or article, the process comprising the steps of:
(a) contacting the substrate or article with a solution comprising the antimicrobial oligopeptide of claim 1 ; and
(b) optionally drying the substrate or article produced in step (a).
16. A process for preparing an antimicrobial oligopeptide comprising:
(a) synthesizing monomeric tri-peptide units of claim 1 ; and
(b) synthesizing full-length oligopeptides by fragment condensation or polymerization of the monomeric tri-peptide units.
17. The process of claim 16 , wherein step (a) comprises solid-phase synthesis or solution-phase synthesis.
18. A method for killing, inhibiting, or preventing the growth of at least one microbe, the method comprising contacting the microbe with an effective amount of the antimicrobial oligopeptide of claim 1 .
19. A method for killing, inhibiting, or preventing the growth of at least one microbe, the method comprising bringing the microbe into contact with the antimicrobial substrate of claim 8 .